within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AB02_AntithrombinIii;

model AntithrombinIii
  extends Pharmacolibrary.Drugs.ATC.B.B01AB02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>AntithrombinIii</td></tr><tr><td>ATC code:</td><td>B01AB02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Antithrombin III is a naturally occurring inhibitor of several coagulation enzymes, primarily thrombin and factor Xa. It is used therapeutically as a replacement therapy in patients with hereditary or acquired antithrombin deficiency, often to prevent thromboembolic events during high-risk procedures. Antithrombin III (human plasma-derived or recombinant) is approved and used clinically.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adults and patients with hereditary antithrombin deficiency; administered as intravenous bolus or infusion.</p><h4>References</h4><ol><li><p>Moffett, BS, et al., &amp; Yee, DL (2017). Population pharmacokinetics of human antithrombin concentrate in paediatric patients. <i>British journal of clinical pharmacology</i> 83(11) 2450–2457. DOI:<a href=\"https://doi.org/10.1111/bcp.13359\">10.1111/bcp.13359</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28664670/\">https://pubmed.ncbi.nlm.nih.gov/28664670</a></p></li><li><p>Marzo, A, et al., &amp; Parenti, M (2002). Pharmacokinetic behaviour of antithrombin III following intravenous infusion in healthy volunteers. <i>Arzneimittel-Forschung</i> 52(3) 187–193. DOI:<a href=\"https://doi.org/10.1055/s-0031-1299878\">10.1055/s-0031-1299878</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11963646/\">https://pubmed.ncbi.nlm.nih.gov/11963646</a></p></li><li><p>Bateman, RM, et al., &amp; Prandi, E (2016). 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. <i>Critical care (London, England)</i> 20(Suppl 2) 94–None. DOI:<a href=\"https://doi.org/10.1186/s13054-016-1208-6\">10.1186/s13054-016-1208-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27885969/\">https://pubmed.ncbi.nlm.nih.gov/27885969</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end AntithrombinIii;
